CCND1 and hepatocellular carcinoma: Other studies showed in hepatocellular carcinoma cell lines that PTK787 treatment alone reduced AKT-phosphorylation, Cyclin D1 and anti-apoptotic Bcl-2 protein expression, which correlated with cell cycle retardation/arrest and reduced cell growth (36).